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1. Introduction 
Chances are relatively high that each of us will experience low back pain at some point in 
our lives. The usual course is rapid improvement with 5% to 10% developing persistent 
symptoms.1 In the 1990s the estimated cost of low back pain to the health industry was in 
the billions of dollars, and with a larger proportion of our population now reported to be 
older, this number can only be expected to increase. 2, 3 Treatment typically begins with 
conservative measures such as medication and physical therapy and may even include 
minimally and highly invasive pain management interventions. Surgery is sometimes 
required in patients who have progressive neurologic deficits or those who do not respond 
to conservative treatment sometimes chose surgery. A quandary sometimes arises, 
following a primary surgery, as to whether repeat surgery should be attempted or another 
alternative technique should be tried. This is the exact problem that the epidural 
adhesiolysis procedure was designed to address. Failed back surgery or postlaminectomy 
syndrome led to the development of the epidural adhesiolysis procedure.  
It was shown to be effective in many patients with chronic pain after back surgery 
presumably by freeing up nerves and breaking down scar formation, delivering site-specific 
corticosteroids and local anesthetics, and reducing edema with the use of hyaluronidase and 
hypertonic saline. Epidural adhesiolysis has afforded patients a reduction in pain and 
neurologic symptoms without the expense and occasional long recovery period associated 
with repeat surgery, and often prevents the need for surgical intervention. Epidural 
adhesiolysis was given an evidence rating of strong correlating to a 1B or 1C evidence level 
for post–lumbar surgery syndrome in the most recent American Society of Interventional 
Pain Physicians evidence-based guidelines. The therapy is supported by observational 
studies and case series along with randomized-control trials. The recommendation was also 
made that this therapy could apply to most patients with post laminectomy syndrome or 
failed back syndrome in many circumstances with informed consent.4 Additionally, current 
procedural terminology (CPT) codes have been assigned to the two different kinds of 
adhesiolysis: CPT 62263 for the three-times injections over 2 to 3 days, usually done in an 
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inpatient hospital setting, and CPT 62264 for the one-time injection series surgery-center 
model that may need to be repeated 3 to 3.5 times in a 12-month period. 
2. Pathophysiology of epidural fibrosis (scar tissue) as a cause of low back 
pain with radiculopathy 
The etiology of chronic low back pain with radiculopathy after appropriate surgery is not 
well understood. Kuslich et al5 addressed this issue when they studied 193 patients who had 
undergone lumbar spine operations given local anesthesic int the epidural space. It was 
postulated that sciatica could only be produced by stimulation of a swollen, stretched, 
restricted (i.e., scarred) or compressed nerve root.5 Back pain could be produced by 
stimulation of several tissues, but the most common tissue of origin was the outer layer of 
the annulus fibrosus and the posterior longitudinal ligament. Stimulation for pain 
generation of the facet joint capsule rarely generated low back pain, and facet synovium and 
cartilage surfaces of the facet or muscles were never tender.6  
The contribution of fibrosis to the etiology of low back pain has been debated.7–9 There are 
many possible etiologies of epidural fibrosis, including surgical trauma, an annular tear, 
infection, hematoma, or intrathecal contrast material.10 These etiologies have been well 
documented in the literature. LaRocca and Macnab11 demonstrated the invasion of fibrous 
connective tissue into postoperative hematoma as a cause of epidural fibrosis, and Cooper et 
al12 reported periradicular fibrosis and vascular abnormalities occurring with herniated 
intervertebral disks. McCarron et al13 investigated the irritative effect of nucleus pulposus 
on the dural sac, adjacent nerve roots, and nerve root sleeves independent of the influence of 
direct compression on these structures. Evidence of an inflammatory reaction was identified 
by gross inspection and microscopic analysis of spinal cord sections after homogenized 
autogenous nucleus pulposus was injected into the lumbar epidural space of four dogs. In 
the control group consisting of four dogs injected with normal saline, the spinal cord 
sections were grossly normal. Parke and Watanabe14 showed significant evidence of 
adhesions in cadavers with lumbar disk herniation.  
It is widely accepted that postoperative scar renders the nerve susceptible to injury by a 
compressive phenomena.9 It is natural for connective tissue or any kind of scar tissue to 
form fibrous layers (scar tissue) as a part of the process that transpires after disruption of the 
intact milieu.15 Scar tissue is generally found in three components of the epidural space. 
Dorsal epidural scar tissue is formed by reabsorption of surgical hematoma and may be 
involved in pain generation.16 In the ventral epidural space, dense scar tissue is formed by 
ventral defects in the disk, which may persist despite surgical treatment and continue to 
produce low back pain and radiculopathy past the surgical healing phase.17 The lateral 
epidural space includes the epiradicular structures outside the root canals, known as the 
lateral recesses or “sleeves,” which are susceptible to lateral disk defects, facet hypertrophy, 
and neuroforaminal stenosis.18  
Although scar tissue itself is not tender, an entrapped nerve root is. Kuslich et al5 surmised 
that the presence of scar tissue compounded the pain associated with the nerve root by 
fixing it in one position and thus increasing the susceptibility of the nerve root to tension or 
compression. They also concluded that no other tissues in the spine are capable of 
producing leg pain. In a study of the relationship between peridural scar evaluated by 
magnetic resonance imaging (MRI) and radicular pain after lumbar diskectomy, Ross et al19 
demonstrated that subjects with extensive peridural scarring were 3.2 times more likely to 
experience recurrent radicular pain.  
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This evidence also parallels a new study by Gilbert et al20 in which lumbosacral nerve roots 
were identified as undergoing less strain than previously published during straight leg raise 
and in which hip motion greater than 60 degrees was determined to cause displacement of 
the nerve root in the lateral recess. 
3. Fluid foraminotomy: Foraminal adhesiolysis or disentrapment  
Relative or functional foraminal root entrapment syndrome secondary to epidural fibrosis 
with corresponding nerve root entrapment is frequently evident after an epidurogram and 
signified by lack of epidural contrast flow into epidural finger projections at those levels. The 
lysis procedure effectively serves as a fluid foraminotomy reducing foraminal stenosis caused 
by epidural fibrosis. In addition to increasing foraminal cross-sectional area, adhesiolysis 
serves to decompress distended epidural venous structures that may exert compression at 
nearby spinal levels (Fig. 1) and inevitably cause needle stick related epidural hematomas. 
Adhesiolysis has led to the development of flexible epiduroscopy that is being pioneered by, 
primarily initiated, pursued and to this day supported by Dr. James Heavner.21,22 
 
 
Fig. 1. Engorged blood vessels in the epidural cavity as observed during epiduroscopy. 
Insert in upper right corner is fluoroscopy showing location for epiduroscopy tip (left 
anterior border of L5) 
4. Diagnosis and radiologic diagnosis of epidural fibrosis 
As with any patient, a thorough musculoskeletal and neurologic examination should be 
performed. In addition to standard dural tension provocative tests, we recommend a 
provocative test called ‘dural tug’. To perform the test, the patient should be instructed to sit 
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up with a straight leg, bend forward flexing the lumbar spine until their back pain starts to 
become evident, and the head and neck flexed rapidly forward. During this maneuver, the 
dura is stretched cephalad and if adhered to structures such as the posterior longitudinal 
ligament, the most heavily innervated spinal canal structure, the movement of the dura will 
elicit back pain that is localized to the pain generator. A positive dural tug maneuver has 
been observed to resolve after percutaneous neuroplasty. (Fig 2 A-E) 
 
 
A    B  
 
C  
Fig. 2. A-C. A) The ‘dural tug’ maneuver being performed prior to percutaneous 
neuroplasty. B) Note pain reproduction prior to full neck flexion secondary to dural 
adhesions. C) Patient after percutaneous neuroplasty with pain free neck and back flexion 
due to treatment of dural adhesions. 
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Fig. 2. D-E. D) There is decreased spine flexion prior to treatment secondary to dural 
adhesions. E) After treatment, the same patient demonstrates increased painless flexion of 
the spine.  
MRI and computed tomography (CT) are diagnostic tools; sensitivity and specificity are 50% 
and 70%, respectively.15 CT myelography may also be helpful, although none of the 
aforementioned modalities can identify epidural fibrosis with 100% reliability. In contrast, 
epidurography is a technique used with considerable success and it is believed that epidural 
fibrosis is best diagnosed by performing an epidurogram.23–26 It can detect filling defects in 
good correlation with a patient's symptoms in real time.26 A combination of several of these 
techniques would undoubtedly increase the ability to identify epidural fibrosis. 
5. Current Procedural Terminology or CPT codes 
The American Medical Association has developed Current Procedural Terminology codes 
for epidural adhesiolysis, which include 62264 for a single infusion and 62263 for a staged 
three-series infusion. 
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6. Indications for epidural adhesiolysis 
Although originally designed to treat radiculopathy secondary to epidural fibrosis following 
surgery, the use of epidural adhesiolysis has been expanded to treat a multitude of pain 
etiologies. These include the following27: 
1. Failed back surgery syndrome  
2. Postlaminectomy syndrome of the neck and back after surgery 
3. Disk disruption 
4. Metastatic carcinoma of the spine leading to compression fracture 
5. Multilevel degenerative arthritis 
6. Facet pain 
7. Spinal stenosis 
8. Pain unresponsive to spinal cord stimulation and spinal opioids 
9. Thoracic disk related chest wall and abdominal pain (after mapping) 
7. Contraindications 
The following are absolute contraindications for performing epidural adhesiolysis: 
1. Sepsis 
2. Chronic infection 
3. Coagulopathy 
4. Local infection at the procedure site 
5. Patient refusal 
6. Syrinx formation 
A relative contraindication is the presence of arachnoiditis. With arachnoiditis, the tissue 
planes may be adherent to one another, increasing the chance of loculation of contrast or 
medication. It may also increase the chance of spread of the medications to the subdural or 
subarachnoid space, which can increase the chance of complications. Practitioners with 
limited experience with epidural adhesiolysis should consider referring these patients to a 
clinician with more training and experience. 
8. Patient preparation 
When epidural adhesiolysis has been deemed an appropriate treatment modality, the risks 
and benefits of the procedure should be discussed with the patient and informed consent 
obtained. The benefits are pain relief, improved physical function, and possible reversal of 
neurologic symptoms. Risks include, but are not limited to, bruising, bleeding, infection, 
reaction to medications used (i.e., hyaluronidase, local anesthetic, corticosteroids, hypertonic 
saline), damage to nerves or blood vessels, no or little pain relief, bowel/bladder 
incontinence, worsening of pain, and paralysis. Patients with a history of urinary 
incontinence should have a urodynamic evaluation by a urologist before the procedure to 
document the preexisting urodynamic etiology and pathology. 
9. Anticoagulant medication 
Medications that prolong bleeding and clotting parameters should be withheld before 
performing epidural adhesiolysis. The length of time varies depending on the medication 
taken. A consultation with the patient's primary physician should be obtained before 
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stopping any of these medications, particularly in patients who require chronic 
anticoagulation such as those with drug-eluting heart stents or prosthetic heart valves. 
Nonsteroidal anti-inflammatory drugs and aspirin, respectively, should be withheld 4 days 
and 7 to 10 days before the procedure. Although there is much debate regarding these 
medications and neuraxial procedures, we tend to be on the conservative side. Clopidogrel 
(Plavix) should be stopped 7 days before, whereas ticlopidine (Ticlid) is withheld 10 to 14 
days before the adhesiolysis.28 Warfarin (Coumadin) stoppage is variable but 5 days is 
usually adequate.27 Patients on subcutaneous heparin should have it withheld a minimum 
of 12 hours before the procedure, whereas those on low-molecular-weight heparin require a 
minimum of 24 hours.28 Over-the-counter homeopathic medications that prolong bleeding 
parameters should also be withheld. These include fish oil, vitamin E, gingko biloba, garlic, 
ginseng, and St. John's Wort. Adequate coagulation status can be confirmed by the history, 
INR, prothrombin time, partial thromboplastin time, and a platelet function assay or 
bleeding time. The tests should be performed as close to the day of the procedure as 
possible. Tests performed only a few days after stopping the anticoagulant medication may 
come back elevated because not enough time has elapsed to allow the anticoagulant effects 
of the medication to resolve. The benefits of the procedure must be weighed against the 
potential sequelae of stopping the anticoagulant medication and this should be discussed 
thoroughly with the patient. 
10. Preoperative laboratory 
Before the procedure, a complete blood count and a clean-catch urinalysis are obtained to 
check for any undiagnosed infections. An elevated white count and/or a positive urinalysis 
should prompt the physician to postpone the procedure and refer the patient to the primary 
care physician for further workup and treatment. In addition, history of bleeding, 
abnormalities a prothrombin time, partial thromboplastin time, and platelet function assay 
or bleeding time, are obtained to check for coagulation abnormalities. Any elevated value 
warrants further investigation and postponement of the procedure until those studies are 
complete.  
11. Technique 
This procedure can be performed in the cervical, thoracic, lumbar, and caudal regions of the 
spine. The caudal and transforaminal placement of catheters will be described in detail, 
whereas highlights and slight changes in protocol will be provided for cervical and thoracic 
catheters. Our policy is to perform this procedure under strict sterile conditions in the 
operating room. Prophylactic antibiotics with broad neuraxial coverage are given before the 
procedure. Patients will receive either ceftriaxone 1 g intravenously or Levaquin 500 mg 
orally in those allergic to penicillin. The same dose is also given on day 2. An 
anesthesiologist or nurse anesthetist provides monitored anesthesia care. 
12. Caudal approach 
The patient is placed in the prone position with a pillow placed under the abdomen to 
correct the lumbar lordosis and a pillow under the ankles for patient comfort. The patient is 
asked to put his or her toes together and heels apart. This relaxes the gluteal muscles and 
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facilitates identification of the sacral hiatus. After sterile preparation and draping, the sacral 
hiatus is identified via palpation just caudal to the sacral cornu or with fluoroscopic 
guidance. A skin wheal is raised with local anesthetic 1-inch lateral and 2 inches caudal to 
the sacral hiatus on the side opposite the documented radiculopathy. A distal subcutaneous 
approach theoretically provides some protection from meningitis, as a local skin infection 
would be much preferred over infection closer to the caudal epidural space. The skin is 
nicked with an 18-gauge cutting needle, and a 15- or 16-gauge RX Coudé (Epimed 
International) epidural needle is inserted through the nick at a 45-degree angle and guided 
fluoroscopically or by palpation to the sacral hiatus (Figs. 3 and 4). 
When the needle is through the hiatus, the angle of the needle is dropped to 
approximately 30 degrees and advanced. The advantages of the RX Coudé needle over 
other needles are the angled tip, which enables easier direction of the catheter, and the tip 
of the needle is less sharp. The back edge of the distal opening of the needle is designed to 
be a noncutting surface that allows manipulation of the catheter in and out of the needle. 
A Touhy needle has the back edge of the distal opening, which is a cutting surface and 
can more easily shear a catheter. A properly placed needle will be inside the caudal canal 
below the level of the S3 foramen on anteroposterior (AP) and later fluoroscopic images. 
A needle placed above the level of the S3 foramen could potentially puncture a low-lying 
dura. The needle tip should cross the midline of the sacrum toward the side of the 
radiculopathy.  
 
 
 
Fig. 3. Caudal lysis sequence—first find sacral hiatus and tip of coccyx. 
www.intechopen.com
 Epidural Lysis of Adhesions and Percutaneous Neuroplasty 
 
345 
 
 
 
 
 
Fig. 4. Roll palpating index finger to identify the sacral cornu and thus the target sacral 
hiatus. 
An epidurogram is performed using 10 mL of a non-ionic, water-soluble contrast  
agent. Confirm a negative aspiration for blood or cerebrospinal fluid before any injection 
of the contrast or medication. Omnipaque and Isovue are the two agents most frequently 
used and are suitable for myelography.29, 30 Do not use ionic, water-insoluble agents such 
as Hypopaque or Renografin or ionic, water-soluble agents such as Conray. 31,32 These 
agents are not indicated for myelography. Accidental subarachnoid injections can lead to 
serious untoward events such as seizure and possibly death. Slowly inject the contrast 
agent and observe for filling defects. A normal epidurogram will have a “Christmas tree” 
pattern with the central canal being the trunk and the outline of the nerve roots making 
up the branches. An abnormal epidurogram will have areas where the contrast does not 
fill (Fig. 5). These are the areas of presumed scarring and typically correspond to the 
patient's radicular complaints. If vascular uptake is observed, the needle needs to be 
redirected. 
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Fig. 5. Initial dye injection Omnipaque 240 (10 mL) showing sacral S3 runoff and filling 
defects at S2, S1, and right L5 
After turning the distal opening of the needle ventral lateral, insert a TunL Kath or TunL-XL 
(stiffer) catheter (Epimed International) with a bend on the distal tip through the needle 
(Figs. 6 and 7). The bend should be 2.5 cm from the tip of the catheter and at a 30-degree 
angle. The bend will enable the catheter to be steered to the target level (Fig 8). Under 
continuous AP fluoroscopic guidance, advance the tip of the catheter toward the ventral-
lateral epidural space of the desired level. The catheter can be steered by gently twisting the 
catheter in a clockwise or counterclockwise direction. Avoid “propellering” the tip (i.e., 
twisting the tip in circles) because this makes it more difficult to direct the catheter. Do not 
advance the catheter up the middle of the sacrum because this makes guiding the catheter to 
the ventral-lateral epidural space more difficult. Ideal location of the tip of the catheter in 
the AP projection is in the foramen just below the midportion of the pedicle shadow (Figs 9 
and 10). Check a lateral projection to confirm that the catheter tip is in the ventral epidural 
space.  
 
 
Fig. 6. The needle is placed through the sacral hiatus into the sacral canal and rotated in the 
direction of the target. Do not advance beyond the S3 foramen. 
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Fig. 7. The Epimed Racz catheter is marked for the location of the bend, or use the thumb as 
reference for the 15-degree angle bend 
 
 
Fig. 8. The direction of the catheter is just near the midline; direct the curve under 
continuous fluoroscopic guidance to the ventral lateral target site. The needle rotation, as 
well as the catheter navigation, may need to be used to reach the target 
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Fig. 9. The needle is removed, and the catheter is placed in the ventral lateral epidural space 
ventral to the nerve root 
 
 
Fig. 10. Catheter (24xL) is threaded to lateral L5 neural foramen 
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Under real-time fluoroscopy, inject 2 to 3 mL of additional contrast through the catheter in 
an attempt to outline the “scarred in” nerve root (Fig 11). If vascular uptake is noted, 
reposition the catheter and reinject contrast. Preferably there should not be vascular runoff, 
but infrequently secondary to venous congestion, an epidural pattern is seen with a small 
amount of vascular spread. This is acceptable as long as the vascular uptake is venous in 
nature and not arterial. Extra caution should be taken when injecting the local anesthetic to 
prevent local anesthetic toxicity. Toxicity is volume and dose related and so far there has not 
been any reported complications from small volume venous spread. Any arterial spread of 
contrast always warrants repositioning of the catheter. We have never observed intra-
arterial placement in 25 years of placing soft, spring-tipped catheters.  
 
 
Fig. 11. Contrast injection Omnipaque 240, additional 5 mL opening right L5, S1, S2, and S3 
perineural spaces; also left L5, S1, S2, and S3 in addition to right L4 spread in cephalad 
direction 
Inject 1500 U of hyaluronidase dissolved in 10 mL of preservative-free normal saline. A newer 
development is the use of Hylenex or human-recombinant hyaluronidase, which carries the 
advantage of a reportedly increased effectiveness at the body's normal pH compared to 
bovine-recombinant hyaluronidase.33 This injection may cause some discomfort, so a slow 
injection is preferable. Observe for “opening up”(i.e. visualization) of the “scarred in” nerve 
root (Figs 12 and 13 ; see also Fig. 11). A 3 mL test dose of a 10 mL local anesthetic/steroid 
(LA/S) solution is then given. Our institution used 4 mg of dexamethasone mixed with 9 mL 
of 0.2% ropivacaine. Ropivacaine is used instead of bupivacaine for two reasons: the former 
produces a preferential sensory versus a motor block, and it is less cardiotoxic than a racemic 
bupivacaine. Doses for other corticosteroids commonly used are 40 to 80 mg of 
methylprednisolone (Depo-Medrol), 25 to 50 mg of triamcinolone diacetate (Aristocort), 40 to 
80 mg of triamcinolone acetonide (Kenalog), and 6 to 12 mg of betamethasone (Celestone Solu 
span). If, after 5 minutes, there is no evidence of intrathecal or intravascular injection of 
medication, inject the remaining 7 mL of the LA/S solution.  
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Fig. 12. Additional contrast and hyaluronidase injection opens up bilaterally formerly 
scarred areas. The Christmas tree appearance is obvious. 
 
 
 
Fig. 13. Catheter advances to the desired symptomatic level of right L5 in the ventral lateral 
epidural space. Injection of contrast followed by 10 mL hyaluronidase 1,500 units opens up 
bilaterally L3-5, S1, S2, and S3 neural foramina. 
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Remove the needle under continuous fluoroscopic guidance to ensure the catheter remains 
at the target level (Fig 14). Secure the catheter to the skin using nonabsorbable suture and 
coat the skin puncture site with antimicrobial ointment. Apply a sterile dressing and attach a 
0.2 μ m filter to the end of the catheter. Affix the exposed portion of the catheter to the 
patient with tape and transport the patient to the recovery area.  
 
 
Fig. 14. Five picture sequence of removal of the needle to prevent dislodging the catheter 
from target site before suturing and application of dressing. 
A 20- to 30-minute period should elapse between the last injection of the LA/S solution and 
the start of the hypertonic saline (10%) infusion. This is necessary to ensure that a subdural 
injection of the LA/S solution has not occurred. A subdural block mimics a subarachnoid 
block but it takes longer to establish, usually 16 to 18 minutes. Evidence for subdural or 
subarachnoid spread is the development of motor block. If the patient develops a 
subarachnoid or subdural block at any point during the procedure, the catheter should be 
removed and the remainder of the adhesiolysis canceled. The patient needs to be observed 
to document the resolution of the motor and sensory block and to document that 10 mL of 
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the hypertonic saline is then infused through the catheter over 15 to 30 minutes. If the 
patient complains of discomfort, the infusion is stopped and an additional 2 to 3 mL of 0.2% 
ropivacaine is injected and the infusion is restarted. Alternatively, 50 to 75 μ g of fentanyl 
can be injected epidurally in lieu of the local anesthetic. After completion of the hypertonic 
saline infusion, the catheter is slowly flushed with 2 mL of preservative-free normal saline 
and the catheter is capped.  
Our policy is to admit the patient for 24-hour observation status and do a second and a third 
hypertonic saline infusion the following day. On post–catheter insertion day 2, the catheter 
is twice injected (separated by 4- to 6-hour increments) with 10 mL of 0.2% ropivacaine 
without steroid and infused with 10 mL of hypertonic saline (10%) using the same technique 
and precautions as the day 1 infusion. At the end of the third infusion, the catheter is 
removed and a sterile dressing applied. The patient is discharged home with 5 days of oral 
cephalexin at 500 mg twice a day or oral levofloxacin (Levaquin) at 500 mg once a day for 
penicillin-allergic patients. Clinic follow-up is in 30 days.  
13. Transforaminal catheters 
Patients with an additional level of radiculopathy or those in whom the target level cannot 
be reached by the caudal approach may require placement of a second catheter. The second 
catheter is placed into the ventral epidural space via a transforaminal approach.  
After the target level is identified with an AP fluoroscopic image, the superior endplate of the 
vertebra that comprises the caudal portion of the foramina is “squared,” that is, the anterior 
and posterior shadows of the vertebral endplate are superimposed. The angle is typically 15 to 
20 degrees in a caudocephalad direction. The fluoroscope is then oblique approximately 15 
degrees to the side of the radiculopathy and adjusted until the spinous process is rotated to the 
opposite side. This fluoroscope positioning allows the best visualization of the superior 
articular process (SAP) that forms the inferoposterior portion of the targeted foramen. The 
image of the SAP should be superimposed on the shadow of the disk space on the oblique 
view. The tip of the SAP is the target for the needle placement (Fig 15). Raise a skin wheal 
slightly lateral to the shadow of the tip of the SAP. Pierce the skin with an 18-gauge needle and 
then insert a 15- or 16-gauge RX Coudé needle and advance using gun-barrel technique 
toward the tip of the SAP. Continue to advance the needle medially toward the SAP until the 
tip contacts bone. Rotate the tip of the needle 180 degrees laterally and advance about 5 mm 
(Fig 16). Rotate the needle back medially 180 degrees (Fig 17).  
 
 
Fig. 15. Transforaminal lateral-oblique view. Target the SAP with the advancing RX Coude 
needle. 
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Fig. 16. Following bony contact with SAP. Lateral rotation of 180 degrees to allow passage 
toward the target. 
 
 
Fig. 17. Note the intertransverse ligament. The needle tip with the RX Coude 2 that has 1 
mm protruding blunt stylet will pass through the ligament and will be less likely to damage 
the nerve. 
As the needle is advanced slowly, a clear “pop” is felt as the needle penetrates the inter 
transverse ligament. Obtain a lateral fluoroscopic image. The tip of the needle should be just 
past the SAP in the posterior foramen. In the AP plane, the tip of the needle under 
continuous AP fluoroscopy, insert the catheter slowly into the foramen and advance until 
the tip should be just short of the middle of the spinal canal (Fig 18 to 20).  
 
 
 
Fig. 18. The distal tip of the catheter may be bent 15-degrees, 3/4 inch length. 
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Fig. 19. Once the intertransverse ligament is perforated, the catheter is steered to the ventral 
lateral epidural space (lateral view). 
 
 
 
Fig. 20. Transforaminal 15-gauge RX-Coude 2 (Epimed International, Johnstown, NY) 
catheter at left L3-4 threaded almost to near midcanal position (anteroposterior view). 
Confirm that the catheter is in the anterior epidural space with a lateral image (Fig 21). 
Anatomically, the catheter is in the foramen above or below the exiting nerve root (Fig 22). If 
the catheter cannot be advanced, it usually means the needle is either too posterior or too 
lateral to the foramen. It can also indicate that the foramen is too stenotic to allow passage of 
the catheter. The needle can be advanced a few millimeters anteriorly in relation to the 
foramen, and that will also move it slightly medial into the foramen. If the catheter still will 
not pass, the initial insertion of the needle will need to be more lateral. Therefore the 
fluoroscope angle will be about 20 degrees instead of 15 degrees. The curve of the needle 
usually facilitates easy catheter placement. The final position of the catheter tip is just short 
of the midline. 
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Fig. 21. Lateral view of Fig. 169-13 . Transforaminal-ventral-anterior catheter dye spread to 
epidural and L3-4 intradiscal area (through annular tear). 
 
 
Fig. 22. Anteroposterior view. The catheter is in optimal position near midline via the 
transforaminal placement. 
Inject 1 to 2 mL of contrast to confirm epidural spread. When a caudal and a transforaminal 
catheter are placed, the 1500 U of hyaluronidase are divided evenly between the two 
catheters (5 mL of the hyaluronidase/saline solution into each). The LA/S solution is also 
divided evenly, but a volume of 15 mL (1 mL steroid and 14 mL 0.2% ropivacaine; of the 
total volume, 5 mL is transforaminal and 10 mL is caudal) is used instead of 10 mL. Remove 
the needle under fluoroscopic guidance to make sure the catheter does not move from the 
original position in the epidural space. Secure and cover the catheter as described 
previously. The hypertonic saline solution is infused at a volume of 4 to 5 mL per 
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transforaminal and 8 to 10 mL per caudal catheter over 30 minutes. The hypertonic saline 
injection volume should always be less than or equal to the local anesthetic volume injected 
to avoid pain from injection. It behooves the practitioner to check the position of the 
transforaminal catheter under fluoroscopy before performing the second and third 
infusions. The catheter may advance across the epidural space into the contralateral foramen 
or paraspinous muscles or more commonly back out of the epidural space into the 
ipsilateral paraspinous muscles. 
This results in deposition of the medication in the paravertebral tissue rather than in the 
epidural space. As with the caudal approach, remove the transforaminal catheter after the 
third infusion. A recent development is the R-X Coude 2 needle in which a second 
protruding stylet may allow closer needle placement and less chance of nerve injury. 
14. Cervical lysis of adhesions 
The success of the caudal approach for lysis of adhesions led to the application of the same 
technique to the cervical epidural space. The indications and preprocedure workup are the 
same as those for the caudal lysis technique, but there are a few differences in technique and 
volumes of medication used.  
The epidural space should be entered via the upper thoracic interspaces using a paramedian 
approach on the contralateral side. The most common levels are T1-2 and T2-3. Entry at 
these levels allows for a sufficient length of the catheter to remain in the epidural space after 
the target level has been reached. If the target is the lower cervical nerve roots, a more 
caudal interspace should be selected. We place the patient in the left lateral decubitus 
position, but use a prone approach in larger patients.  
A technique referred to as the “3-D technique” is used to facilitate entry into the epidural 
space. The “3-D” stands for direction, depth, and direction. Using an AP fluoroscopic image, 
the initial direction of the 15- or 16-gauge RX Coudé needle is determined. Using a modified 
paramedian approach with the skin entry one and a half levels below the target interlaminar 
space, advance and direct the needle toward the midpoint of the chosen interlaminar space 
with the opening of the needle pointing medial. Once the needle engages the deeper tissue 
planes (usually at 2 to 3 cm), check the depth of the needle with a lateral image. Advance the 
needle toward the epidural space and check repeat images to confirm the depth. The 
posterior border of the dorsal epidural space can be visualized by identifying the junction of 
the base of the spinous process of the vertebra with its lamina. This junction creates a 
distinct radiopaque “straight line.” Once the needle is close to the epidural space, obtain an 
AP fluoroscopic image to recheck the direction of the needle. If the tip of the needle has 
crossed the midline as defined by the spinous processes of the vertebral bodies, pull the 
needle back and redirect. The “3-D” process can be repeated as many times as is necessary 
to get the needle into the perfect position. 
Using loss-of-resistance technique, advance the needle into the epidural space with the tip of 
the RX-Coudé needle, pointed caudally. Once the tip is in the epidural space, rotate the tip 
cephalad, and inject 1 to 2 mL of contrast to confirm entry. Rotation or movement of any 
needle in the epidural space can cut the dura. This technique has been improved with the 
advent of the RX Coudé 2 needle, which has a second interlocking stylet that protrudes 
slightly beyond the tip of the needle and functions to push the dura away from the needle 
tip as it is turned 180 degrees cephalad (Fig. 23 A-E).  
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Fig. 23. Sequence of stages to place a catheter using the R-X Coude. A and B. The needle is 
inserted into the epidural space with the tip directed as shown. C. The protruding stylet is 
inserted. D. Then the needle is rotated so the tip is parallel to the dura. E. The catheter is 
inserted. 
Inject an additional small volume as needed to complete the epidurogram. If there is no free 
flow of injected contrast, pressure may build up in the lateral epidural space. Characteristic 
fluid spread by the path of least resistance can be recognized as perivenous counter spread 
(PVCS). Presence of PVCS means pressure builds up in the lateral epidural space that is 
unable to spread laterally to decompress. The dye spread picks the path of least resistance to 
the opposite side. Pressure may build up and lead to ischemic spinal cord injury. Flexion 
and rotation of the head and neck can open up lateral runoff and release the pressure 
through the enlarged neural foramina (Fig 24)34 
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Fig. 24. Flexion rotation, left to right regardless patient position. The neural foramen 
enlarges on flexion rotation and gets smaller with extension. The inferior pars slides forward 
over the superior pars to enlarge the foramen. This allows lateral run off and pressure 
release with PVCS. 
As with the caudal epidurogram, look for filling defects. It is extremely important to 
visualize spread of the contrast in the cephalad and caudal directions. Loculation of 
contrast in a small area must be avoided as this can significantly increase the pressure in 
the epidural space and can compromise the already tenuous arterial blood supply to the 
spinal cord. Place a bend on the catheter as previously described for the caudal approach 
and insert it through the needle (Fig 23E). The opening of the needle should be directed 
toward the target side. Slowly advance the catheter to the lateral gutter and direct it 
cephalad. Redirect the catheter as needed and once the target level has been reached, turn 
the tip of the catheter toward the foramen (Fig 25A). Inject 0.5 to 1 mL of contrast to 
visualize the target nerve root. Make sure there is runoff of contrast out of the foramen 
(Fig 25B). Slowly instill 150 U of Hylenex dissolved in 5 mL of preservative-free normal 
saline. Follow this with 1 to 2 mL of additional contrast and observe for “opening up” of 
the “scarred in” nerve root. Give a 2 mL test dose of a 6 mL solution of LA/S. Our 
combination is 5 mL of 0.2% ropivicaine and 4 mg of dexamethasone. If after 5 minutes 
there is no evidence of intrathecal or intravascular spread, inject the remaining 4 mL. 
Remove the needle, and secure and dress the catheter as previously described. Once 20 
minutes have passed since the last dose of LA/S solution and there is no evidence of a 
subarachnoid or subdural block, start an infusion of 5 mL of hypertonic saline over 30 
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minutes. At the end of the infusion, flush the catheter with 1 to 2 mL of preservative-free 
normal saline and cap the catheter.  
 
 
 
 
Fig. 25. A & B. A Cervical left ventral lateral catheter to the upper level of fusion C5-7.  
B Cervical-left ventral lateral catheter threaded to above level of fusion of C4. The dye 
injection spreads cephalad and lateral. 
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The second and third infusions are performed on the next day with 6 mL of 0.2% 
ropivacaine without spread and 5 mL of hypertonic saline using the same technique and 
precautions described for the first infusion. The catheter is removed and prophylactic 
antibiotics are prescribed. Clinic follow-up is 30 days.  
15. Thoracic lysis of adhesions 
The technique for entry into the thoracic epidural space for adhesiolysis is identical to that 
for the cervical region. Always remember the 3-D technique. Make sure to get a true lateral 
when checking the depth of the needle. This can be obtained by superimposing the rib 
shadows on one another. The target is still the ventrolateral epidural space with the tip of 
the catheter in the foramen of the desired level. The major difference for thoracic lysis 
compared to the caudal and cervical techniques is the volumes of the various injectates. 
Volumes of 8 mL are used for the contrast, Hylenex, LA/S, and hypertonic saline. (Table 1) 
lists typical infusion volumes for epidural adhesiolysis. 
 
 
 Contrast 
Hyaluronidase 
and Normal 
Saline 
Local Anesthetic 
and Steroid 
10% Hypertonic 
Saline Infusion 
Caudal 10 mL 10 mL 10 mL 10 mL 
Caudal and 
transforaminal 
5 mL in each 
catheter 
5 mL in each 
catheter 
5 mL in each 
catheter 
8 mL in caudal 
catheter and  
4 mL in 
transforaminal 
catheter 
Thoracic 8 mL 8 mL 8 mL 8 mL 
Cervical 5 mL 6 mL 6 mL 5 mL 
Table 1. Typical Infusion Volumes for Epidural Adhesiolysis 
16. Neural flossing 
The protocol for epidural adhesiolysis has been aided by neural flossing exercises that were 
designed to mobilize nerve roots by “sliding” them in and out of the foramen (Fig 26). This 
breaks up weakened scar tissue from the procedure and prevents further scar tissue 
deposition. If these exercises are done effectively three to four times per day for a few 
months after the procedure, the formation of scar tissue will be severely restricted. 
In patients with multilevel radiculopathy and complex pain, it can be difficult to determine 
from where the majority of the pain is emanating. We have been using a technique that we 
have termed mapping to locate the most painful nerve root with stimulation and then carry 
out the adhesiolysis at that level. There are several references in the literature regarding the 
use of stimulation to confirm epidural placement of a catheter and for nerve root 
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localization.35 The TunL Kath and the TunL-XL catheter can be used as stimulating catheters 
to identify the nerve root(s). 
 
 
 
 
Fig. 26. A-F Neural flossing exercises. A, Standing erect, firmly grasp a stable surface  
(e.g., a door frame) with outstretched arm. Press elbow and shoulder forward. B, Next, 
slowly tilt head in opposite direction from outstretched arm to achieve gentle tension.  
C, Finally, rotate chin toward opposite shoulder as is comfortable. Hold this final position 
for approximately 20 to 30 seconds. D, Lay down supine on an exercise mat without a 
pillow. Slowly bring both knees close to the chest with bent legs and hold this position  
for 20 seconds. Release and assume a neutral position. E, Again in supine position, raise 
both legs to 90 degrees, with knees straight while laying flat on a firm surface. Hold for 20 
seconds. Assume a neutral position and rest briefly. F, Bring both legs to a 90-degree angle 
while lying supine. Slowly spread legs in a V shape, as much as is comfortable, and hold for 
20 seconds.Epidural Mapping 
After entering the epidural space, advance the catheter into the ventrolateral epidural 
space past the suspected target level. Make sure the tip of the catheter is pointing laterally 
toward the foramina, just below the pedicle. Pull the catheter stylet back approximately 1 
cm. Using alligator clips, attach the cathode to the stylet and ground the anode on the 
needle or ground pad or a 22-gauge needle inserted into the skin. Apply electrical 
stimulation with a stimulator box with a rate of 50 pulses per second and a pulse width of 
450 milliseconds, dialing up the amplitude until a paresthesia is perceived in small 
increments, usually less than 2 or 3 volts. Inquire of the patient as to whether or not the 
paresthesia is felt in the area of the patient's recognized greatest pain. This process is 
repeated at each successive level until the most painful nerve root is identified. Once 
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identified, the adhesiolysis is carried out at that level. The mapping procedure is also 
useful to identify the optimal site of surgery either before the first surgery or when 
surgery has failed one or more times.  
17. Complications 
As with any invasive procedure, complications are possible. These include bleeding, 
infection, headache, damage to nerves or blood vessels, catheter shearing, bowel/bladder 
dysfunction, paralysis, spinal cord compression from loculation of the injected fluids or 
hematoma, subdural or subarachnoid injection of local anesthetic or hypertonic saline, and 
reactions to the medications used. We also include on the consent form that the patient may 
experience an increase in pain or no pain relief at all. Although the potential list of 
complications is long, the frequency of complications is very rare. However, there is clearly 
a learning curve, and recent studies reflect this by the significantly improved long-term 
outcome and the very rare publications of complications and medicolegal consequences 
when one considers the ever-increasing clinical experience.  
Subdural spread is a complication that should always be watched for when injecting local 
anesthetic. During the caudal adhesiolysis, particularly if the catheter is advanced along the 
midline, subdural catheter placement is a risk (Figs 27 and 28). Identification of the subdural 
motor block should occur within 16 to 18 minutes. Catheters used for adhesiolysis should 
never be directed midline in the epidural space.  
 
 
 
 
 
 
Fig. 27. Midline catheter placement enters subdural space. There is also some epidural dye 
spread. But the patient starts to complain of bilateral leg pain. 
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Fig. 28. A 22-gauge spinal needle and extension set with syringe placed in the subdural 
space and 12 mL fluid aspirated. The patient reported immediate reversal of bilateral leg 
pain. Note the dye in the extension tubing and syringe at the 7-o'clock position. 
18. Outcomes 
Initially in the early 1980s the protocol was designed to direct site-specific medication onto 
the dorsal root ganglion; however, after performing a number of the procedures, it was 
found that the dorsal root ganglion was exceptionally hard to reach secondary to 
developing scar tissue or adhesions. In the early days, our understanding was coming from 
the use of local anesthetics for surgery giving a 2- to 4-hour block for the surgeon to operate. 
It was gratifying to see chronic pain patients get months and years of pain relief following 
the placement of the new steerable x-ray visible catheter. The early report in 1985 by Racz et 
al36 described the use of phenol at the dorsal root ganglion followed by an observational 
listing of outcomes that were clearly not as good as the latest studies on failed back surgery 
and spinal stenosis showing 75% to 80% improvement at 12 months' follow-up by 
Manchikanti.34 Initially we were pleased to see some patients getting 3 to 4 months of relief 
and report seeing recovery of footdrops. This philosophy still proves to be true even in 
studies in 2008 by Sakai et al 37 in which they found that adhesiolysis with catheter-directed 
steroid and local anesthetic injection during epiduroscopy alleviated pain and reduced 
sensory nerve dysfunction in patients with chronic sciatica. The evolution of these findings 
has changed the process into what it is today.38 Racz and Holubec first reported on epidural 
adhesiolysis in 1989.39 There were slight variations in the protocol compared to today's 
protocol, namely the dose of local anesthetic and the fact that hyaluronidase was not used. 
Catheter placement was lesion-specific (i.e., the tip of the catheter was placed in the foramen 
corresponding to the vertebral level and side of the suspected adhesions). The retrospective 
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analysis conducted 6 to 12 months after the procedure reported initial pain relief in 72.2% of 
patients ( N = 72) at time of discharge. Relief was sustained in 37.5% and 30.5% of patients at 
1 and 3 months, respectively. Forty-three percent decreased their frequency and dosage of 
medication use and 16.7% discontinued their medications altogether. In total, 30.6% of 
patients returned to work or returned to daily functions. In April 1990, at a presentation of 
the 7th IASP World Congress on Pain in Adelaide, Austraila, Arthur et al40 reported on 
epidural adhesiolysis in 100 patients, 50 of whom received hyaluronidase as part of the 
procedure. In the hyaluronidase group, 81.6% of the participants had initial pain relief, with 
12.3% having persistent relief; 68% of the no hyaluronidase group had relief of pain, with 
14% having persistent relief at the end of the 3-year follow-up period from which the study 
sample was randomly selected. 
In 1994 Stolker et al41 added hyaluronidase to the procedure, but omitted the hypertonic 
saline. In a study of 28 patients, they reported greater than 50% pain reduction in 64% of 
patients at 1 year. They stressed the importance of the patient selection and believed that the 
effectiveness of adhesiolysis was based on the effect of the hyaluronidase on the adhesions 
and the action of the local anesthetic and steroids on the sinuvertebral nerve.  
Devulder et al42 published a study of 34 patients with failed back surgery syndrome in 
whom epidural fibrosis was suspected or proved with MRI.42 An epidural catheter was 
inserted via the sacral hiatus to a distance of 10 cm into the caudal canal. Injections of 
contrast dye, local anesthetic, corticosteroid, and hypertonic saline (10%) were carried out 
daily for 3 days. No hyaluronidase was used. Filling defects were noted in 30 of 34 patients, 
but significant pain relief was noted in only 7 patients at 1 month, 2 patients at 3 months, 
and no patients at 12 months. They concluded that epidurography may confirm epidural 
filling defects for contrast dye in patients with filling defects, but a better contrast dye 
spread, assuming scar lysis does not guarantee sustained pain relief. This study was 
criticized for lack of lesion-specific catheter placement resulting in nonspecific drug 
delivery.43 The catheter was never directed to the ventral lateral epidural space where the 
dorsal root ganglion is located and the lateral recess scarring occurs.  
Heavner et al44 performed a prospective randomized trial of lesion-specific epidural 
adhesiolysis on 59 patients with chronic intractable low back pain. The patients were 
assigned to one of four epidural adhesiolysis treatment groups: (1) hypertonic (10%) saline 
plus hyaluronidase, (2) hypertonic saline, (3) isotonic (0.9%) saline, or (4) isotonic saline plus 
hyaluronidase. All treatment groups received corticosteroid and local anesthetic. Overall, 
across all four treatment groups, 83% of patients had significant pain relief at 1 month 
compared to 49% at 3 months, 43% at 6 months, and 49% at 12 months. The hyaluronidase 
and the hypertonic saline study group had a much lower incidence of additional need for 
pain procedures than the placebo groups, showing that site-specific catheter placement is 
important. Active substances and preservative free normal saline were blinded for the 
placebo effect. 
Manchikanti et al45 performed a retrospective randomized evaluation of a modified Racz 
adhesiolysis protocol in 232 patients with low back pain. The study involved lesion specific 
catheter placement, but the usual 3-day procedure was reduced to a 2-day (group 1) or a 1-
day (group 2) procedure. Group 1 had 103 patients and group 2 had 129 patients. Other 
changes included changing the local anesthetic from bupivacaine to lidocaine, substituting 
methylprednisolone acetate or betamethasone acetate and phosphate for triamcinolone 
diacetate, and reduction of the volume of injectate. Of the patients in groups 1 and 2, 62% 
and 58% had greater than 50% pain relief at 1 month, respectively, with these percentages 
www.intechopen.com
 Epidural Lysis of Adhesions and Percutaneous Neuroplasty 
 
365 
decreasing to 22% and 11% at 3 months, 8% and 7% at 6 months, and 2% and 3% at 1 year. 
Of significant interest is that the percentage of patients receiving greater than 50% pain relief 
after four procedures increased to 79% and 90% at 1 month, 50% and 36% at 3 months, 29% 
and 19% at 6 months, and 7% and 8% at 1 year for groups 1 and 2, respectively. Short-term 
relief of pain was demonstrated, but long-term relief was not.  
Manchikanti, in 1999, evaluated two groups of randomly pulled, 150 patients for a 2-day 
reinjection procedure, and a second 150 patients for a one-day procedure out of a pool of 536 
patients. It was concluded that repeat use of the one-day procedure is also cost effective 
when evaluated on a 12-month follow-up. The cost effectiveness indicated the lysis 
procedure to be superior to surgery or the rehabilitation activity program.45  
In a randomized, prospective study, Manchikanti et al46 evaluated a 1-day epidural 
adhesiolysis procedure against a control group of patients who received conservative 
therapy. Results showed that cumulative relief, defined as relief greater than 50% with 
one to three injections, in the treatment group was 97% at 3 months, 93% at 6 months, and 
47% at 1 year. The study also showed that overall health status improved significantly in 
the adhesiolysis group. Conservative therapy consisted of physical therapy and 
medications. 
In 2004 Manchikanti et al47 published their results of a randomized, double-blind, 
controlled study on the effectiveness of 1-day lumbar adhesiolysis and hypertonic saline 
neurolysis in treatment of chronic low back pain. Seventy-five patients whose pain was 
unresponsive to conservative modalities were randomized into one of three treatment 
groups. Group 1 (control group) underwent catheterization where the catheter was in the 
sacral canal without adhesiolysis, followed by injection of local anesthetic, normal saline, 
and steroid. Group 2 consisted of catheterization with site-specific catheter placement 
being ventral-lateral for adhesiolysis, followed by injection of local anesthetic, normal 
saline, and steroid. Group 3 consisted of site-specific catheter placement for adhesiolysis, 
followed by injection of local anesthetic, hypertonic saline, and steroid. Patients were 
allowed to have additional injections based on the response, either after unblinding or 
without unblinding after 3 months. Patients without unblinding were offered either the 
assigned treatment or another treatment based on their response. If the patients in group 1 
or 2 received adhesiolysis and injection and injection of hypertonic saline, they were 
considered withdrawn, and no subsequent data were collected. Outcomes were assessed 
at 3, 6, and 12 months using visual analog scale pain scores, Oswestry Disability Index, 
opioid intake, range-of-motion measurement, and P-3. Significant pain relief was defined 
as average relief of 50% or greater. Seventy-two percent of patients in group 3, 60% of 
patients in group 2, and 0% of patients in group 1 showed significant pain relief at 12 
months. The average number of treatments for 1 year was 2.76 in group 2 and 2.16 in 
group 3. Duration of significant relief with the first procedure was 2.8 + 1.49 months and 
3.8 + 3.37 months in groups 2 and 3, respectively. Significant pain relief (>50%) was also 
associated with improvement in Oswestry Disability Index, range of motion, and 
psychologic status.  
Manchikanti et al48,49, furthered this research using comparisons of percutaneous 
adhesiolysis versus fluoroscopically guided caudal epidural steroid injections. The first 
study involved a population of patients with chronic low back pain and known spinal 
stenosis. The results showed a 76% reduction in pain relief at 1 year with epidural 
adhesiolysis compared to 4% in the control group. The second study performed in a 
population of patients with post–lumbar surgery syndrome showed a reduction in pain and 
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improvement in functional status in 73% of the epidural adhesiolysis group compared to 
12% in the control group.  
In 2006 a study by Veihelmann et al50 evaluated patients with a history of chronic low back 
pain and sciatica. Inclusion criteria were radicular pain with a corresponding nerve root 
compressing substrate found on MRI or CT. All patients were randomized to receive 
physiotherapy, analgesics, or lysis of adhesions. The lysis group had statistically 
significantly better outcome than the physical therapy treatment group.  
Two other prospective evaluations by Chopra et al and Gerdesmeyer et al51, 52 evaluated 
patients with monosegmental radiculopathy of the lumbar spine. All the patients suffered 
from chronic disk herniations or failed back syndrome. All these randomized trials showed 
positive short-term and long-term relief. Two prospective evaluations also showed positive 
short- and long-term relief.51,52 
19. Conclusion 
Epidural adhesiolysis has evolved over the years as an important treatment option for 
patients with intractable cervical, thoracic, and low back and leg pain. Studies show that 
patients are able to experience significant pain relief and restoration of function. 
Manchikanti's studies show that the amount and duration of relief can be achieved by repeat 
procedures. Recent prospective randomized double-blind studies on failed back surgery and 
spinal stenosis show 75% and 80% improvement in visual analog scale scores and functional 
improvements at 12 months' follow-up. There have been no negative studies to date where 
the lysis target was the ventral-lateral epidural space. The one negative study used a 10 cm 
sacral mid-canal catheter placement which was non-target specific.43 This negative study 
was subsequently used as the placebo group in a study performed by Manchikanti.47 
Manchikanti’s study consisted of 3 treatment groups: placebo (sacral mid-canal catheter 
placement), target specific ventral-lateral epidural without hypertonic saline and target 
specific ventral-lateral epidural with hypertonic saline . The later two treatment groups had 
positive outcomes with the hypertonic saline group superior; whereas, the placebo group 
did not. 47 The evolution in the recognition of the site-specific importance of the catheter and 
medication delivery together with the fact that physicians need to acquire the skills to be 
able to carry out the procedure led to the improved outcomes seen in recent prospective 
randomized studies.  
The management of failed back surgery syndrome and post laminectomy syndrome will 
likely continue to be controversial among the multitude of practitioners who treat these 
patients. However, in experienced hands, it is established as a reasonable option for many 
patients. 
Percutaneous neuroplasty via a transforaminal approach evolved from the caudal approach. 
Lysis of adhesions via the caudal approach involves introducing a catheter through the 
sacral hiatus and advancing it to the affected nerve root in the ventral-lateral epidural space. 
On the other hand, transforaminal percutaneous neuroplasty achieves a midline catheter 
placement in the epidural space that is able to target the two most heavily innervated 
structures in the spine—the posterior annulus fibrosus and the posterior longitudinal 
ligament.5 Apart from a surgical approach, the ventral epidural structures have been 
otherwise inaccessible.  
Endoscopy offers direct visualization of the affected nerve roots in addition to mechanical 
adhesiolysis, and may become more mainstream as the technique is refined.  
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Facet pain is commonly associated with the postlysis period or after provocative testing a 
month or so later if two-facet diagnostic blocks show efficacy. In addition to epidural lysis of 
adhesions, the combined use of radiofrequency facet denervation gives us the best long-
term outcome.  
Epidural adhesiolysis has been accepted as a treatment for post laminectomy syndrome, 
failed back syndrome, and cervical and thoracic radicular syndromes. Additional studies are 
underway to further refine the technique and indications. The combined use of long term 
patient education for neural flossing exercises and the inclusion of the facet delayed 
treatment in the algorithm further improves patient outcome. The identification of back pain 
provocation by saline injection and the successful use of percutaneous neuroplasty in the 
treatment represents hopeful promise for a cost effective treatment of back pain.  
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